PLX icon

Protalix BioTherapeutics
PLX

Overview Fund Activity

43 hedge funds and large institutions have $76.5M invested in Protalix BioTherapeutics in 2014 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 14 increasing their positions, 13 reducing their positions, and 9 closing their positions.

Holders
43
Holders Change
-2
Holders Change %
-4.44%
% of All Funds
1.25%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
7
Increased
14
Reduced
13
Closed
9
Calls
$101K
Puts
$627K
Net Calls
-$526K
Net Calls Change
+$1.81M

Top Buyers

1
CCM
1
Consonance Capital Management
New York
$12.2M
2
MMH
2
Menora Mivtachim Holdings
Israel
$2.91M
3
Deutsche Bank
3
Deutsche Bank
Germany
$637K
4
TC
4
TFS Capital
Pennsylvania
$657K
5
BCM
5
Bridgeway Capital Management
Texas
$484K

Top Sellers

1
Allianz Asset Management
1
Allianz Asset Management
Germany
$0
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$0
3
Federated Hermes
3
Federated Hermes
Pennsylvania
$23M
4
State of New Jersey Common Pension Fund D
4
State of New Jersey Common Pension Fund D
New Jersey
$0
5
GPP
5
Great Point Partners
Connecticut
$0
Name Market Value Shares Shares
Change 		Shares
Change %
WAM
51
Wolverine Asset Management
Illinois
– – – –
Barclays
52
Barclays
United Kingdom
$0 57 – –
Ameriprise
53
Ameriprise
Minnesota
$0 25 – –
1 2
3